NutriBand (NTRB) Total Non-Current Liabilities (2019 - 2024)
NutriBand's (NTRB) quarterly Total Non-Current Liabilities came in at $1.5 million in Q2 2024, up 83.73% quarter-over-quarter from $811738.0 in Q4 2023.
NutriBand (NTRB) Total Non-Current Liabilities (2019 - 2024) Analysis & Trends
NutriBand has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $1.5 million for Q2 2024.
- Total Non-Current Liabilities for Q2 2024 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Apr 2024 was $1.5 million (changed N/A YoY), and the FY2020 annual result was $1.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities came in at $1.5 million for Q2 2024 at NutriBand, up from $811738.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $2.8 million in Q4 2020 to a low of $725903.0 in Q2 2020.
- The 3-year median for Total Non-Current Liabilities is $998090.0 (2020), against an average of $1.3 million.
- Peak annual rise in Total Non-Current Liabilities reached 247.14% in 2020, while the deepest fall reached 217.98% in 2020.
- NutriBand's Total Non-Current Liabilities stood at $2.8 million in 2020, then slumped by 71.27% to $811738.0 in 2023, then surged by 83.73% to $1.5 million in 2024.
- The last three Total Non-Current Liabilities figures came in at $1.5 million (Q2 2024), $811738.0 (Q4 2023), and $2.8 million (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 64.76 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2024 | 1.49 Mn |
| Oct 31, 2023 | 811,738.00 |
| Oct 31, 2020 | 2.83 Mn |
| Jul 31, 2020 | 902,632.00 |
| Apr 30, 2020 | 725,903.00 |
| Jan 31, 2020 | 1.09 Mn |
| Oct 31, 2019 | 888,648.00 |
| Apr 30, 2019 | -493,344.00 |